Emerging in the landscape of obesity treatment, retatrutide is a distinct approach. Unlike many current medications, retatrutide functions as a dual agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) and https://royispv101838.newsbloger.com/39346236/a-innovative-retatrutide-the-glp-and-gip-sensor-agonist